Table 5.
Analysis of sex‐related differences in cfPWV levels (ANCOVA) after adjust by age and body height
| Age group | cfPWV, m/s | Before adjustment age, y | Body height, cm | After adjustment by age and body height | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cfPWV, m/s | 95% CI for mean difference | |||||||||||||||
| MV ± SE | P value | MV ± SE | P value | MV ± SE | P value | MV ± SE | 95% CI lower limit | 95% CI upper limit | P value | Mean difference | SE difference | Lower limit | Upper limit | Age, y | Body height, cm | |
| All (9–87 y) | ||||||||||||||||
| Male | 6.43 ± 0.05 | .004 | 32.71 ± 0.58 | <.001 | 170.96 ± 0.50 | <.001 | 5.73 ± 0.04 | 5.65 | 5.81 | 0.180 | −0.113 | 0.084 | −0.278 | 0.052 | 23.07 | 167.78 |
| Female | 6.65 ± 0.06 | 40.77 ± 0.67 | 160.13 ± 0.66 | 5.84 ± 0.07 | 5.71 | 5.97 | ||||||||||
| Children and adolescents (<21 y) | ||||||||||||||||
| Male | 5.31 ± 0.04 | .030 | 15.04 ± 0.09 | .259 | 170.32 ± 0.57 | <.001 | 5.29 ± 0.03 | 5.22 | 5.35 | 0.729 | −0.027 | 0.077 | −0.179 | 0.125 | 15.04 | 168.15 |
| Female | 5.14 ± 0.07 | 14.77 ± 0.31 | 158.94 ± 1.11 | 5.31 ± 0.07 | 5.18 | 5.45 | ||||||||||
| Adults (>21 y) | ||||||||||||||||
| Male | 7.32 ± 0.07 | .001 | 46.37 ± 0.55 | .399 | 174.05 ± 0.79 | <.001 | 7.24 ± 0.20 | 6.85 | 7.63 | 0.758 | 0.088 | 0.285 | −0.476 | 0.652 | 47.33 | 166.66 |
| Female | 7.02 ± 0.06 | 47.04 ± 0.58 | 161.15 ± 0.75 | 7.15 ± 0.15 | 6.86 | 7.45 | ||||||||||
| Adults (quartile 1) | ||||||||||||||||
| Male | 6.27 ± 0.08 | .040 | 29.88 ± 0.36 | .952 | 175.82 ± 1.39 | <.001 | 6.47 ± 0.26 | 5.95 | 7.00 | 0.357 | 0.372 | 0.397 | −0.438 | 1.181 | 29.78 | 169.11 |
| Female | 5.94 ± 0.07 | 29.91 ± 0.40 | 163.60 ± 1.42 | 6.10 ± 0.22 | 5.65 | 6.55 | ||||||||||
| Adults (quartile 2) | ||||||||||||||||
| Male | 6.79 ± 0.11 | .024 | 41.16 ± 0.25 | .278 | 173.60 ± 1.68 | <.001 | 6.93 ± 0.38 | 6.16 | 7.69 | 0.908 | −0.064 | 0.550 | −1.181 | 1.053 | 41.32 | 166.67 |
| Female | 6.47 ± 0.09 | 40.82 ± 0.20 | 162.15 ± 0.80 | 6.99 ± 0.28 | 6.42 | 7.56 | ||||||||||
| Adults (quartile 3) | ||||||||||||||||
| Male | 7.74 ± 0.12 | .309 | 51.77 ± 0.21 | .115 | 173.70 ± 1.26 | .04 | 7.88 ± 0.29 | 7.26 | 8.49 | 0.083 | 0.794 | 0.433 | −0.115 | 1.703 | 50.86 | 168.91 |
| Female | 7.57 ± 0.12 | 51.29 ± 0.23 | 164.92 ± 2.23 | 7.08 ± 0.26 | 6.53 | 7.63 | ||||||||||
| Adults (quartile 4) | ||||||||||||||||
| Male | 8.52 ± 0.13 | .028 | 63.82 ± 0.46 | .018 | 172.54 ± 1.80 | <.001 | 7.85 ± 0.58 | 6.69 | 9.02 | 0.663 | −0.343 | 0.780 | −1.926 | 1.239 | 66.90 | 163.20 |
| Female | 8.13 ± 0.11 | 65.55 ± 0.57 | 157.23 ± 1.30 | 8.20 ± 0.34 | 7.50 | 8.90 | ||||||||||
ANCOVA, analysis of covariance; cfPWV, carotid‐femoral pulse wave velocity; CI, confidence interval; MV, mean value; SE, standard error.
P value obtained using unpaired two‐tailed test comparing male and female groups.